ORION-1

Advertisement

cGxPJobs Banner

Avenzo Reports Promising Phase 1 Data for AVZO-021 in HR+ Breast Cancer

SAN DIEGO, Calif., June 1, 2026 Avenzo Therapeutics announced updated clinical results from the Phase 1 portion of its...

By cGxPwire Editor
June 2, 2026

Read More

Avenzo Therapeutics Advances Dual CDK Inhibitor Breast Cancer Study

SAN DIEGO, Calif., April 28, 2026 Avenzo Therapeutics, Inc. has announced the initiation of the combination cohort in its...

By cGxPwire Editor
April 29, 2026

Read More

Advertisement

cGxPJobs

Directory